Document Type
Presentation
Loading...
Media is loading
Publication Date
10-17-2012
Abstract
Objectives:
1. Rich history of WASOG as a forum
2. Consider the current state of research in sarcoidosis including limitations
3. Briefly review the results of the latest biologic trial for sarcoidosis
Presentation: 57 minutes
Recommended Citation
Kavuru, Mani, "Highlights from World Association of Sarcoidosis and Other Granulomatous Disorders North America Conference 2012" (2012). Division of Pulmonary and Critical Care Medicine Presentations and Grand Rounds. Presentation 63.
https://jdc.jefferson.edu/pulmcritcaregrandrounds/63
COinS
Comments
Dr. Kavuru is a pulmonary and critical care clinician scientist with a long-standing interest and experience in a variety of lung disorders, translational research, and multi-center clinical trials. I am the Division Director and are responsible for growing a robust academic pulmonary and critical care program that excels both regionally and nationally. I am board-certified in both pulmonary and critical care medicine and I am a Professor at Thomas Jefferson University Hospital in center city Philadelphia. I trained at The Cleveland Clinic Foundation and was on faculty there for 14 years, and was the Director of the PFT lab for 10 years. I was instrumental in starting the Sarcoidosis Center at CCF. I have an active clinical practice at Jefferson in both the outpatient setting as well as the hospital medical ICU. I am a co-director of the Jefferson Center for Critical Care. In these administrative capacities, I am involved in critical care from an organizational perspective and closely interface with intersivists from several disciplines as well as the emergency department. I have been a PI on a variety of pulmonary clinical trials over 20 years ranging from asthma, sarcoidosis, sepsis, ARDS, and pulmonary alveolar proteinosis. I have participated in a variety of NIH-funded consortia [i.e. Sarcoid Genetic Analysis (SAGA) consortium, Rare Lung Disease Consortium] and a variety of RO-1s as a co-investigator or a PI on the parent trails. Currently, I am a co-investigator on a pharma-funded sepsis study and an ARDS study and I have been the PI on several prior multi-center studies. I have authored or co-authored over 100 original publications. I have co-mentored 3 junior faculty in NIH K awards. Overall goal for our division is to provide world-class patient care with compassion, train the best pulmonary physicians, and contribute to advances for the future of our specialty. We wish to do this by broad-based collaborations and partnerships in a collegial atmosphere.